Clinical and Functional Characterization of Novel GALNT3 Mutations in a Chinese Child with Hyperphosphatemic Familial Tumoral Calcinosis
International Journal of Molecular Sciences · 18.03.2026 · 27 (6) · 2767
DOI: 10.3390/ijms27062767 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.03.2026. Verfasst von Yuan Gao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Hubei Provincial Key Laboratory of Pediatric Genetic Metabolic and Endocrine Rare Diseases, Hubei Provincial Clinical Resea…. Hauptthemen laut MEDLINE: Calcinosis, Hyperostosis, Cortical, Congenital, Hyperphosphatemia, Mutation. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Key Research and Development Program of China, Natural Science Foundation of Hubei Province.
Abstract (Originalsprache)
Hyperphosphatemic familial tumoral calcinosis (HFTC) is a rare autosomal recessive disorder characterized by hyperphosphatemia and ectopic calcifications. Mutations in GALNT3, which encodes a key enzyme responsible for O-glycosylation of FGF23, represent a major genetic cause of HFTC. This modification is essential for the stability and secretion of FGF23. We investigated a 4-year and 6-month-old Chinese girl with HFTC to characterize the clinical features, identify the causative variants, and explore the underlying pathogenic mechanism. Whole-exome sequencing followed by Sanger validation identified novel compound heterozygous variants in GALNT3 (c.659T>A, p.Ile220Asn and c.1850C>A, p.Ser617*). The patient exhibited hyperphosphatemia with a biochemical profile consistent with FGF23 deficiency, including extremely low intact FGF23 and elevated C-terminal fragments. Functional studies using Western blotting and wheat germ agglutinin affinity chromatography demonstrated that the mutant GALNT3 caused a severe defect in FGF23 O-glycosylation, leading to impaired secretion of intact FGF23. Glycosylated FGF23 was detected only in the medium of cells expressing wild-type GALNT3. These findings indicate that defective O-glycosylation results in failure of FGF23 secretion and functional inactivation. This study expands the mutational spectrum of GALNT3 and provides mechanistic insight into the role of GALNT3 in phosphate homeostasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Hubei Provincial Key Laboratory of Pediatric Genetic Metabolic and Endocrine Rare Diseases, Hubei Provincial Clinical Research Center for Children's Growth and Development and Metabolic Disease…
ORCID-Profile: Yuan Gao, Xiaoping Luo
Förderung
- the National Key Research and Development Program of China
- Natural Science Foundation of Hubei Province
Zitieren
APA
Gao, Y., Zhang, C., Wu, S., Ying, Y., Hou, L., Liang, Y., & Luo, X. (2026). Clinical and Functional Characterization of Novel GALNT3 Mutations in a Chinese Child with Hyperphosphatemic Familial Tumoral Calcinosis. International Journal of Molecular Sciences, 27(6), 2767. https://doi.org/10.3390/ijms27062767
Vancouver
Gao Y, Zhang C, Wu S, Ying Y, Hou L, Liang Y, et al. Clinical and Functional Characterization of Novel GALNT3 Mutations in a Chinese Child with Hyperphosphatemic Familial Tumoral Calcinosis. International Journal of Molecular Sciences. 2026;27(6):2767. doi:10.3390/ijms27062767
BibTeX
@article{Gao2026,
author = {Gao, Yuan and Zhang, Cai and Wu, Shimin and Ying, Yanqin and Hou, Ling and Liang, Yan and Luo, Xiaoping},
title = {Clinical and Functional Characterization of Novel GALNT3 Mutations in a Chinese Child with Hyperphosphatemic Familial Tumoral Calcinosis},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {6},
pages = {2767},
doi = {10.3390/ijms27062767}
}
EUVIMED